Company profile
Biodel company profile
Biodel Inc. (Biodel) is a development-stage company. The Company is a biopharmaceutical company focused on the development and commercialization of treatments for diabetes. It develops its product candidates by applying its formulation technologies to existing drugs. Its product candidate is Linjeta. It has formulated Linjeta as rapid-acting mealtime insulin for the treatment of patients with Type I and Type II diabetes. Earlier stage product candidates include follow-on and second generation rapid-acting mealtime insulins or insulin analogs, VIAtab, a sublingual tablet formulation of insulin, a line of basal insulins, and a formulation of glucagon.
Business identity
- Website
- http://www.biodel.com
- Contact email
- [email protected]
- Phone number
- 2037965003
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $10K+
- Founded
- 2003-01-01
Headquarters
- Headquarters
- Petrolia, Texas, United States
- Postal code
- 06810
- Country code
- US
- Continent
- North America